Fighting America’s Other Drug Problem

Published November 21, 2010

Fighting America’s Other Drug Problem
University of Missouri researchers find key to combating medication non-adherence
Read more on Kansas City InfoZine

Family Therapy: Actors give social work students a chance to practice counseling
JEN WAS THE first of five family members to enter a room with a circle of seven chairs in the middle. Carrying a backpack, she took in the scene with wide eyes. …
Read more on Montana Kaimin

VYTORIN® (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease …
In a new investigational study of VYTORIN® , the cholesterol-lowering medicine from Merck , VYTORIN 10/20 mg reduced the incidence of first major vascular events — defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure — by a highly statistically significant 16.1 percent compared to placebo .
Read more on Business Wire via Yahoo! Finance